These findings not only provide a promising avenue for the development of targeted therapies against TIPE3 in cancer treatment but also establish a model for harnessing sophisticated computational strategies to streamline the discovery and optimization of new inhibitors. This evidence concerns the gene TIPE3 and cancer.